IN2013MU01920A - - Google Patents

Download PDF

Info

Publication number
IN2013MU01920A
IN2013MU01920A IN1920MU2013A IN2013MU01920A IN 2013MU01920 A IN2013MU01920 A IN 2013MU01920A IN 1920MU2013 A IN1920MU2013 A IN 1920MU2013A IN 2013MU01920 A IN2013MU01920 A IN 2013MU01920A
Authority
IN
India
Prior art keywords
disclosed
conditions
thiazolyl
obesity
cancers
Prior art date
Application number
Other languages
English (en)
Inventor
Kunju Vasu Kamala
Suresh Thacker Pavitra
Anilkumar Sharma Jayesh
Abhiramasundari A
Original Assignee
Kamala K Vasu Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kamala K Vasu Dr filed Critical Kamala K Vasu Dr
Priority to IN1920MU2013 priority Critical patent/IN2013MU01920A/en
Publication of IN2013MU01920A publication Critical patent/IN2013MU01920A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN1920MU2013 2013-05-31 2013-05-31 IN2013MU01920A (ru)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN1920MU2013 IN2013MU01920A (ru) 2013-05-31 2013-05-31

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1920MU2013 IN2013MU01920A (ru) 2013-05-31 2013-05-31

Publications (1)

Publication Number Publication Date
IN2013MU01920A true IN2013MU01920A (ru) 2015-09-25

Family

ID=54394961

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1920MU2013 IN2013MU01920A (ru) 2013-05-31 2013-05-31

Country Status (1)

Country Link
IN (1) IN2013MU01920A (ru)

Similar Documents

Publication Publication Date Title
HK1222552A1 (zh) 索布替羅用於治療髓鞘形成疾病
HRP20180631T1 (hr) Analog mini-gastrina, posebno u uporabi za dijagnozu i/ili liječenje tumora pozitivnog na receptor cck2
MX2016003129A (es) Terapia de combinacion de anticuerpos contra el csf-1r humano y anticuerpos contralel pd-l1 humano.
MX366804B (es) Translocaciones de la r-espondina y sus metodos de uso.
MX2016004678A (es) Composiciones para el tratamiento del cancer.
MX2015015249A (es) Peptidos terapeuticos.
PH12015501071A1 (en) Combination therapy of anti-her3 antibodies
GEP201706612B (en) Methods for the treatment of breast cancer
HK1219232A1 (zh) 用於癌症治療的具有減弱的對 抗體的交叉反應性的精氨酸脫亞胺酶
MX365403B (es) Peptidos y metodos para usarlos.
PH12015500169A1 (en) Prediction of treatment response to jak/stat inhibitor
WO2014197835A3 (en) Methods and compositions for the treatment of cancer
IN2015DN00515A (ru)
HK1214752A1 (zh) 由產甲烷菌引起或與之相關的疾病及病狀的診斷、選擇及治療方法
EP3015864A4 (en) Biomarkers for the diagnosis and the response to treatment of pancreatic cancer
MX2015010023A (es) Anticuerpos anti-cd83 y su uso.
EP3030268A4 (en) Combination of ifn-gamma with anti-erbb antibody for the treatment of cancers
GB2516814B (en) Use of phytocannabinoids for increasing radiosensitivity in the treatment of cancer
PH12016501183A1 (en) Novel compound for treatment of severe hypoglycemia
EP2983693A4 (en) SEPT4 / ARTS AS A TUMOR SUPPRESSOR IN THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF HEPATIC DISORDERS
PH12016501184A1 (en) Novel compound for treatment of severe hypoglycemia
PH12016501182A1 (en) Novel compound for treatment of severe hypoglycemia
LT2984108T (lt) Anti-s100a7 antikūnai, skirti vėžio gydymui ir diagnozei
PL2943215T3 (pl) Peptydy pochodzące z laktoferycyny do zastosowania w leczeniu nowotworu
IN2013MU01920A (ru)